The PopVax Chronicles

The PopVax Chronicles

Home
Archive
About
Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1
PopVax’s influenza vaccine designs elicit as much as 250x greater antibody titer against seasonal strains than existing approved flu vaccines, as well…
Jan 3 • 
Soham Sankaran
3

Share this post

The PopVax Chronicles
The PopVax Chronicles
Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1

December 2024

PopVax updates – NIH NIAID will conduct the Phase I trial for our COVID-19 vaccine + Gates Foundation funding for our thermostable mRNA…
We have some exciting news to share:
Dec 22, 2024 • 
PopVax
2

Share this post

The PopVax Chronicles
The PopVax Chronicles
PopVax updates – NIH NIAID will conduct the Phase I trial for our COVID-19 vaccine + Gates Foundation funding for our thermostable mRNA delivery work

August 2023

The unlikely, inevitable founding of PopVax, Part I: Three meetings and six million funerals
Broadly-protective mRNA vaccines to save millions of lives
Aug 20, 2023 • 
Soham Sankaran
18

Share this post

The PopVax Chronicles
The PopVax Chronicles
The unlikely, inevitable founding of PopVax, Part I: Three meetings and six million funerals
© 2025 PopVax
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share